Portnoy Law Firm Announces Class Action on Behalf of agilon health, inc. Investors

Core Viewpoint - The Portnoy Law Firm is advising investors of agilon health, inc. to participate in a class action lawsuit due to alleged corporate misconduct during the specified class period from February 26, 2025, to August 4, 2025 [1]. Group 1: Legal Action - Investors have until March 2, 2026, to file a lead plaintiff motion in the class action lawsuit [1]. - The Portnoy Law Firm is offering a complimentary case evaluation for investors to discuss their legal rights and options for recovering losses [2]. Group 2: Allegations Against the Company - The complaint alleges that agilon health, inc. failed to disclose that it issued guidance for 2025 that was unrealistic, given known industry challenges [3]. - It is claimed that the company materially overstated the financial benefits from strategic actions intended to mitigate risks [3]. Group 3: Company Events and Stock Impact - On August 4, 2025, agilon announced the resignation of Steven Sell as President, CEO, and Director, which was characterized as a termination without cause [4]. - Following the announcement of disappointing financial results on the same day, agilon's stock price plummeted over 50%, closing at $0.8801 on August 5, 2025 [4].